• BioVaxys Technology Corp. (BIOV) has broadened patent coverage for its viral vaccine platform
  • BioVaxys filed an  international patent application through the Patent Cooperation Treaty (“PCT”) for BVX-1021, its vaccine for SARS1 and other sarbecoviruses
  • CEO James Passin sat down with Sabrina Cuthbert to discuss the news
  • BioVaxys Technology is a clinical-stage biotechnology company that is developing viral and oncology vaccine platforms
  • BioVaxys Technology Corp. (BIOV) opened trading at C$0.11 per share.

BioVaxys Technology Corp. (BIOV) has broadened patent coverage for its viral vaccine platform.

BioVaxys filed an international patent application through the Patent Cooperation Treaty (“PCT”) for BVX-1021, it’s vaccine for SARS1 and other sarbecoviruses.

BVX-1021 is the subject of an ongoing research collaboration between The Ohio State University and BioVaxys that is evaluating the Company’s novel approach for a ‘universal vaccine’ that can treat a broad range of sarbecoviruses. 

An International PCT Application, which is a patent treaty with more than 150 member countries, makes it possible to seek patent protection for an invention simultaneously in a large number of countries by filing a single ‘international’ patent application.

CEO James Passin sat down with Sabrina Cuthbert to discuss the news.

BioVaxys Technology is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumour types.

BioVaxys Technology Corp. (BIOV) opened trading at C$0.11 per share.


More From The Market Online

Avicanna launches 10% CBD (THC free) formula in Canada

Avicanna (TSX:AVCN) launches RHO Phyto Micro Drop 100, a 10 per cent CBD (THC free), proprietary oral formulation in Canada.

@ the Bell: Markets advance on mining and financial support

Canada's main stock index inched higher on Wednesday, tracking an uptick in precious metals prices, though a drop in oil prices capped gains.
The Market Online Video

Prospera Energy plots success with proven reserves, M&A plans

Prospera Energy (TSXV:PEI) CEO Samuel David discusses the company's latest news and the forecast for 2024 in an exclusive interview.